SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-321518
Filing Date
2020-12-18
Accepted
2020-12-18 16:23:54
Documents
13
Period of Report
2020-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d87169d8k.htm   iXBRL 8-K 26935
2 EX-10.1 d87169dex101.htm EX-10.1 16004
  Complete submission text file 0001193125-20-321518.txt   166554

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20201216.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20201216_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20201216_pre.xml EX-101.PRE 10955
6 EXTRACTED XBRL INSTANCE DOCUMENT d87169d8k_htm.xml XML 3244
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 201400899
SIC: 2834 Pharmaceutical Preparations